1 year return (CAGR)
348.17%
Estrella Immunopharma Inc. Exchange (NASDAQ, USD)
ESLAW
0.13
+0.02 (+22.52%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
0.00
Price/Sales
-
Ent value
12.16M
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 0.11 |
| Daily high | 0.13 |
| Daily low | 0.08 |
| Daily Volume | 2K |
| All-time high | 0.56 |
| 1y analyst estimate | - |
| Beta | -0.09 |
| EPS (TTM) | -0.34 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| ESLAW | S&P500 | |
| Current price drop from All-time high | -76.58% | -0.70% |
| Highest price drop | -96.11% | -56.47% |
| Date of highest drop | 25 Jan 2023 | 9 Mar 2009 |
| Avg drop from high | -72.67% | -10.68% |
| Avg time to new high | 65 days | 12 days |
| Max time to new high | 560 days | 1805 days |
News
No items found